Scandinavian Journal of Clinical and Laboratory Investigation · 1953 · 10 citations · 12 references
Protamine SulphatePharmacotherapyOxidative StressGastrointestinal Peptide HormoneMetabolic SyndromeIntravenous InjectionBioanalysisHepatotoxicityClinical ChemistryHealth SciencesBiochemistryLiver PhysiologyHuman BloodEndocrinologyPharmacologyEffect.protamine SulphateDrug-induced Liver InjuryPhysiologyHepatitisClinical PharmacologyMetabolismMedicine
AbstractHeparin in intravenous injection can almost completely suppress and also prevent postalimentary chylomicronemia in man.Large and small doses exert the same effect; even doses of 1 mg of heparin have a very pronounced effect, though it is of shorter duration.The antichylomicronemic effect of heparin in intramuscular injection is less pronounced and very capricious; sublingually, heparin exerts no effect.Protamine sulphate in intravenous injection is capable of counteracting the antichylomicronemic effect of heparin in man.Apparently protamine sulphate increases the spontaneous number of chylomicrons in fasting individuals. But it does not seem to increase the high number of chylomicrons present 2V2 hours after the ingestion of fat.
12
Abolishment of Alimentary Lipemia Following Injection of Heparin
P. F. Hahn · Science · 1943 · 607 citations
Lipoproteins in atherosclerosis
Hardin B. Jones, John W. Gofman, Frank T. Lindgren et al. · The American Journal of Medicine · 1951 · 268 citations
The Role of Heparin in Lipoprotein Metabolism
Edwin Boyle · Science · 1952 · 238 citations
Blood Lipids and Human Atherosclerosis
Dean M. Graham, Thomas P. Lyon, John W. Gofman et al. · Circulation · 1951 · 219 citations